Quidel
Quidel received FDA emergency use authorization on March 1 for its QuickVue At-Home COVID-19 antigen test.
QuickVue is authorized for prescription home use with self-collected nasal swab samples from people ages 14 and older or children ages 8 and older with swabs collected by an adult. It is authorized for people suspected of COVID-19 by their healthcare provider within the first six days of symptom onset.
The antigen test can give results in 10 minutes using a nasal swab sample placed in a test tube followed by a test strip. Colored lines on the test strip indicate positive or negative test results.
